EP 3707149 A1 20200916 - SELENOGALACTOSIDE COMPOUNDS FOR THE TREATMENT OF SYSTEMIC INSULIN RESISTANCE DISORDERS AND THE USE THEREOF
Title (en)
SELENOGALACTOSIDE COMPOUNDS FOR THE TREATMENT OF SYSTEMIC INSULIN RESISTANCE DISORDERS AND THE USE THEREOF
Title (de)
SELENOGALACTOSIDVERBINDUNGEN ZUR BEHANDLUNG VON SYSTEMISCHEN INSULINRESISTENZSTÖRUNGEN UND DEREN VERWENDUNG
Title (fr)
COMPOSÉS DE SÉLÉNOGALACTOSIDE POUR LE TRAITEMENT DE TROUBLES DE LA RÉSISTANCE SYSTÉMIQUE À L'INSULINE ET LEUR UTILISATION
Publication
Application
Priority
- US 201762579343 P 20171031
- US 2018032321 W 20180511
Abstract (en)
[origin: WO2019089080A1] Aspects of the invention relate to novel synthetic compounds having a binding affinity with galectin proteins for the treatment of systemic insulin resistance disorders.
IPC 8 full level
CPC (source: EP IL KR)
A61K 31/7056 (2013.01 - EP IL KR); A61K 31/80 (2013.01 - EP IL KR); A61K 45/06 (2013.01 - EP IL KR); A61P 3/10 (2017.12 - EP IL KR); C07H 5/08 (2013.01 - EP); C07H 19/056 (2013.01 - EP IL KR)
Citation (search report)
See references of WO 2019089080A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019089080 A1 20190509; WO 2019089080 A9 20200723; AU 2018361991 A1 20200514; CA 3080128 A1 20190509; CN 111527097 A 20200811; EP 3707149 A1 20200916; IL 274162 A 20200630; JP 2021501180 A 20210114; KR 20200081443 A 20200707
DOCDB simple family (application)
US 2018032321 W 20180511; AU 2018361991 A 20180511; CA 3080128 A 20180511; CN 201880083771 A 20180511; EP 18874558 A 20180511; IL 27416220 A 20200423; JP 2020524157 A 20180511; KR 20207015450 A 20180511